Dilly S A, Sloane J P
Clin Exp Immunol. 1985 Dec;62(3):545-53.
Using immunohistological techniques, leucocytes were enumerated in portal tracts and bile duct epithelium in bone marrow transplant recipients with and without evidence of hepatic graft versus host disease (GvHD) and compared with normal subjects. Samples were obtained 8-169 days after transplantation. In marrow recipients without graft versus host disease (GvHD), inducer and suppressor/cytotoxic lymphocytes were reduced in number in the portal tracts compared with normal subjects. In GvHD, suppressor/cytotoxic lymphocytes were increased relative to non-GvHD recipients, but did not exceed normal values, while inducer cell numbers remained low. Natural killer cells (HNK1+) were not found in normal subjects, were present in small numbers in non-GvHD transplant cases and significantly increased in GvHD. The total number of portal tract leucocytes was not elevated in GvHD and the changes in the relative proportions of cells were similar to those that have been observed in the peripheral blood after transplantation. There was no increase in the number of lymphocytes expressing the activation markers Tac, T10 and HLA-DR nor in the number of leucocytes within the bile duct epithelium itself. These findings differ from those we have previously obtained in a similarly treated group of patients with cutaneous GvHD where lymphocytes were increased in the epithelium and stroma and expressed activation markers. Like the epidermis of the skin, however, the bile duct epithelium showed increased staining for HLA-DR antigens in all cases, but focal staining was also present in four of the seven marrow recipients without GvHD. The significance of these findings is discussed.
采用免疫组织学技术,对有或无肝移植物抗宿主病(GvHD)证据的骨髓移植受者的门管区和胆管上皮中的白细胞进行计数,并与正常受试者进行比较。样本在移植后8 - 169天获取。在无移植物抗宿主病(GvHD)的骨髓移植受者中,与正常受试者相比,门管区的诱导性淋巴细胞和抑制性/细胞毒性淋巴细胞数量减少。在有GvHD的情况下,与无GvHD的受者相比,抑制性/细胞毒性淋巴细胞数量增加,但未超过正常值,而诱导性细胞数量仍然较低。正常受试者中未发现自然杀伤细胞(HNK1 +),在无GvHD的移植病例中有少量存在,而在有GvHD的情况下显著增加。GvHD患者门管区白细胞总数未升高,细胞相对比例的变化与移植后外周血中观察到的变化相似。表达激活标志物Tac、T10和HLA - DR的淋巴细胞数量以及胆管上皮内白细胞数量均未增加。这些发现与我们之前在一组接受类似治疗的皮肤GvHD患者中获得的结果不同,在皮肤GvHD患者中,上皮和基质中的淋巴细胞增加并表达激活标志物。然而,与皮肤表皮一样,所有病例中胆管上皮的HLA - DR抗原染色均增加,但在7例无GvHD的骨髓移植受者中,有4例也存在局灶性染色。对这些发现的意义进行了讨论。